Design, synthesis, and functional activity of labeled CD1d glycolipid agonists

Bioconjugate Chemistry

Volumn 24, Issue 4, 2013, Pages 586-594

  Jervis, Peter J ^a   Polzella, Paolo ^b   Wojno, Justyna ^a,c   Jukes, John Paul ^b   Ghadbane, Hemza ^b   Garcia Diaz, Yoel R ^a,d   Besra, Gurdyal S ^a   Cerundolo, Vincenzo ^b   Cox, Liam R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL MEMBRANES; CHAINS; CYTOLOGY; FATTY ACIDS; HYDROGEN; MOLECULES; T-CELLS;

CELL/B.E; DESIGN ACTIVITY; DESIGN SYNTHESIS; FUNCTIONAL ACTIVITIES; GLYCO LIPIDS; IN-VIVO; LABELINGS; NATURAL KILLER T CELL; T CELLS RECEPTORS; TERNARY COMPLEX;

CERAMIDES;

ALPHA GALACTOSYL CERAMIDE; BIOTIN; CD1D ANTIGEN; FATTY ACID; GLYCOLIPID; HYDROGEN; IMMUNOMODULATING AGENT; T LYMPHOCYTE RECEPTOR; THREITOL CERAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOKINE RELEASE; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN;

EID: 84876467824     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300556e     Document Type: Article

References (56)

1. Stroynowski, I. (1990) Molecules related to class-I major histocompatibility complex antigens Annu. Rev. Immunol. 8, 501-530
2. Godfrey, D. I., Stankovic, S., and Baxter, A. G. (2010) Raising the NKT cell family Nat. Immunol. 11, 197-206
3. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., and van Kaer, L. (2004) NKT cells: What's in a name? Nat. Rev. Immunol. 4, 231-237
4. Brigl, M. and Brenner, M. B. (2010) How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens Semin. Immunol. 22, 79-86
5. Tupin, E., Kinjo, Y., and Kronenberg, M. (2007) The unique role of natural killer T cells in the response to microorganisms Nat. Rev. Microbiol. 5, 405-417
6. Berzofsky, J. A. and Terabe, M. (2009) The contrasting roles of NKT cells in tumor immunity Curr. Mol. Med. 9, 667-672
7. Terabe, M. and Berzofsky, J. A. (2007) NKT cells in immunoregulation of tumor immunity: A new immunoregulatory axis Trends Immunol. 28, 491-496
8. Wu, L. and Van Kaer, L. (2009) Natural killer T cells and autoimmune diseases Curr. Mol. Med. 9, 4-14
9. Ly, D., Tohn, R., Rubin, B., Blumenfeld, H., Besra, G. S., Veerapen, N., Porcelli, S. A., and Delovitch, T. L. (2010) An α-galactosylceramide C20:2 N -acyl variant enhances anti-inflammatory and regulatory T-cell independent responses that prevent type 1 diabetes Clin. Exp. Immunol. 160, 185-198
10. Mi, Q. A., Ly, D., Zucker, P., McGarry, M., and Delovitch, T. L. (2004) Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells Diabetes 53, 1303-1310
11. Forestier, C., Molano, A., Im, J. S., Dutronc, Y., Diamond, B., Davidson, A., Illarionov, P. A., Besra, G. S., and Porcelli, S. A. (2005) Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black × New Zealand White) F1 mice J. Immunol. 175, 763-770
12. Kobayashi, E., Motoki, K., Yamaguchi, Y., Uchida, T., Fukushima, H., and Koezuka, Y. (1996) Enhancing effects of α-,β-monoglycosylceramides on natural killer cell activity Bioorg. Med. Chem. 4, 615-619
13. Balk, S. P., Bleicher, P. A., and Terhorst, C. (1989) Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule Proc. Natl. Acad. Sci. U.S.A. 86, 252-256
14. α14 NKT cells by glycosylceramides Science 278, 1626-1629
15. For a recent review, see: Banchet-Cadeddu, A., Hénon, E., Dauchez, M., Renault, J.-H., Monneaux, F., and Haudrechy, A. (2012) The stimulating adventure of KRN7000 Org. Biomol. Chem. 9, 3080-3104
16. H2 bias of natural killer T cells Nature 413, 531-534
17. h2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production inflammatory cytokines by bystander cells in vivo Int. Immunol. 17, 1619-1629
18. Schmieg, J., Yang, G., Franck, R. W., and Tsuji, M. (2003) Superior protection against malaria and melanoma metastases by a C -glycoside analogue of the natural killer T cell ligand α-galactosylceramide J. Exp. Med. 198, 1631-1641
19. Yang, G., Schmieg, J., Tsuji, M., and Franck, R. W. (2004) The C-glycoside analogue of the immunostimulant α-galactosylceramide (KRN7000): Synthesis and striking enhancement of activity Angew. Chem., Int. Ed. 43, 3818-3822
20. Araki, M., Miyake, S., and Yamamura, T. (2008) Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapy Curr. Med. Chem. 15, 2337-2345
21. Venkataswamy, M. M., Baena, A., Goldberg, M. F., Bricard, G., Im, J. S., Chan, J., Reddington, F., Besra, G. S., Jacobs, W. R., and Porcelli, S. A. (2009) Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin J. Immunol. 183, 1644-1656
22. Im, J. S., Arora, P., Bricard, G., Molano, A., Venkataswamy, M. M., Baine, I., Jerud, E. S., Goldberg, M. F., Baena, A., Yu, K. O., Ndonye, R. M., Howell, A. R., Yuan, W. M., Cresswell, P., Chang, Y.-T., Illarionov, P. A., Besra, G. S., and Porcelli, S. A. (2009) Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation Immunity 30, 888-898
23. Silk, J. D., Salio, M., Reddy, B. G., Shepherd, D., Gileadi, U., Brown, J., Masri, S. H., Polzella, P., Ritter, G., Besra, G. S., Jones, E. Y., Schmidt, R. R., and Cerundolo, V. (2008) Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells J. Immunol. 180, 6452-6456
24. Reddy, B. G., Silk, J. D., Salio, M., Balamurugan, R., Shepherd, D., Ritter, G., Cerundolo, V., and Schmidt, R. R. (2009) Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells ChemMedChem 4, 171-178
25. 14C]threitol ceramide, non-glycosidic analogues of the potent CD1d antigen α-galactosyl ceramide Tetrahedron: Asymmetry 20, 747-753
26. Wojno, J., Jukes, J.-P., Ghadbane, H., Shepherd, D., Besra, G. S., Cerundolo, V., and Cox, L. R. (2012) Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production ACS Chem. Biol. 7, 847-855
27. Sullivan, B. A., Nagarajan, N. A., Wingender, G., Wang, J., Scott, I., Tsuji, M., Franck, R. W., Porcelli, S. A., Zajonc, D. M., and Kronenberg, M. (2010) Mechanisms for glycolipid antigen-driven cytokine polarization by Vα14 i NKT cells J. Immunol. 184, 141-153
28. Oki, S., Chiba, A., Yamamura, Y., and Miyake, S. (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells J. Clin. Invest. 113, 1631-1640
29. McCarthy, C., Shepherd, D., Fleire, S., Stronge, V. S., Koch, M., Illarionov, P. A., Bossi, G., Salio, M., Denkberg, G., Reddington, F., Tarlton, A., Reddy, B. G., Schmidt, R. R., Reiter, Y., Griffiths, G. M., Van Der Merwe, P. A., Besra, G. S., Jones, E. Y., Batista, F. D., and Cerundolo, V. (2007) The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation J. Exp. Med. 204, 1131-1144
30. Venkataswamy, M. M. and Porcelli, S. A. (2010) Lipid and glycolipid antigens of CD1d-restricted natural killer T cells Semin. Immunol. 22, 68-78
31. Yu, K. O. A., Im, J. S., Molano, A., Dutronc, Y., Illarionov, P. A., Forestier, C., Fujiwara, N., Arias, I., Miyake, S., Yamamura, T., Chang, Y. T., Besra, G. S., and Porcelli, S. A. (2005) Modulation of CD1d-restricted NKT cell responses by using N -acyl variants of α-galactosylceramides Proc. Natl. Acad. Sci. U.S.A. 102, 3383-3388
32. Prigozy, T. I., Naidenko, O., Qasba, P., Elewaut, D., Brossay, L., Khurana, A., Natori, T., Kozeuka, Y., Kulkarni, A., and Kronenberg, M. (2001) Glycolipid antigen processing for presentation by CD1d molecules Science 291, 664-667
33. Park, Y.-K., Lee, J.-W., Ko, Y.-G., Hong, S., and Park, S.-H. (2005) Lipid rafts are required for efficient signal transduction by CD1d Biochem. Biophys. Res. Commun. 327, 1143-1154
34. + lymphocytes as compared with nonprofessional APC J. Immunol. 167, 1188-1197
35. Xia, C., Zhang, W., Zhang, Y., Woodward, R. L., Wang, J., and Wang, P. G. (2009) Facile synthesis of biotin labelled α-galactosylceramide as antigen for invariant natural killer T cells Tetrahedron 65, 6390-6395
36. Zhou, X.-T., Forestier, C., Goff, R. D., Li, C., Teyton, L., Bendelac, A., and Savage, P. B. (2002) Synthesis and NKT cell stimulating properties of fluorophore-and biotin-appended 6″-amino-6″-deoxy- galactosylceramides Org. Lett. 4, 1267-1270
37. Aspeslagh, S., Li, Y., Yu, E. D., Pauwels, N., Trappeniers, M., Girardi, E., Decruy, T., Van Beneden, K., Venken, K., Drennan, M., Leybaert, L., Wang, J., Franck, R. W., Van Calenburgh, S., Zajonc, D. M., and Elewaut, D. (2011) Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis EMBO J. 30, 2294-2305
38. Trappeniers, M., Van Beneden, K., Decruy, T., Hillaert, U., Linclau, B., Elewaut, D., and Van Calenbergh, S. (2008) 6′-Derivatised α-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice J. Am. Chem. Soc. 130, 16468-16469
39. Sakai, T., Ehara, H., and Koezuka, Y. (1999) Synthesis of NBD-α-galactosylceramide and its immunologic properties Org. Lett. 1, 359-361
40. Sakai, T., Naidenko, O. V., Iijima, H., Kronenberg, M., and Koezuka, Y. (1999) Syntheses of biotinylated α-galactosylceramides and their effects on the immune system and CD1 molecules J. Med. Chem. 42, 1836-1841
41. Vo-Hoang, Y., Micouin, L., Ronet, C., Gachelin, G., and Bonin, M. (2003) Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY α-galactosylceramide ChemBioChem 4, 27-33
42. Borg, N. A., Wun, K. S., Kjer-Nielsen, L., Wilce, M. C., Pellicci, D. G., Koh, R., Besra, G. S., Bharadwaj, M., Godfrey, D. I., McCluskey, J., and Rossjohn, J. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor Nature 448, 44-49
43. Poly(ethylene glycol) linkers are commonly used. See, for example: Natarajan, A., Du, W., Xiong, C.-Y., DeNardo, G. L., DeNardo, S. J., and Gervay-Hague, J. (2007) Construction of Di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition Chem. Commun. 695-697
44. Veronese, F. M. and Pasut, G. (2005) PEGylation, successful approach to drug delivery Drug Discovery Today 10, 1451-1458
45. Zalipsky, S. and Harris, J. M. (1997) in Introduction to chemistry and biological applications of poly(ethylene glycol), ACS Symposium Series, Vol. 680, pp 1-13, American Chemical Society, Washington, DC.
46. Schöllkopf, U., Groth, U., and Deng, C. (1981) Enantioselective synthesis of (R)-amino acids using l -valine as a chiral agent Angew. Chem., Int. Ed. 20, 798-799
47. Schöllkopf, U., Hartwig, W., and Groth, U. (1979) Enantioselective synthesis of α-methyl-α-aminocarboxylic acids by alkylation of the lactim ether of cyclo -(l -Ala-l -Ala) Angew. Chem., Int. Ed. 18, 863-864
48. Jones, P., Altamura, S., De Francesco, R., Paz, O. P., Kinzel, O., Mesiti, G., Monteagudo, E., Pescatore, G., Rowley, M., Verdirame, M., and Steinkühler, C. (2008) A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo J. Med. Chem. 51, 2350-2353
49. Gensler, W. J., Alam, I., Prasad, R. S., Radhakrishna, A. I., and Chaudhuri, H. I. (1979) 3-Hydroxy-2-alkyl carboxylic acids related to mycolic acid Tetrahedron 35, 2595-2680
50. Goddard-Borger, E. D. and Stick, R. V. (2007) An efficient, inexpensive and shelf-stable diazotransfer reagent: Imidazole-1-sulfonyl azide hydrochloride Org. Lett. 9, 3797-3800
51. Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. (2002) A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective ligation of azides and terminal alkynes Angew. Chem., Int. Ed. 41, 2596-2599
52. Kolb, H. C., Finn, M. G., and Sharpless, K. B. (2001) Click chemistry: Diverse chemical function from a few good reactions Angew. Chem., Int. Ed. 40, 2004-2021
53. Salio, M., Speak, A. O., Shepherd, D., Polzella, P., Illarionov, P. A., Veerapen, N., Besra, G. S., Platt, F. M., and Cerundolo, V. (2007) Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation Proc. Natl. Acad. Sci. U.S.A. 104, 20490-20495
54. - T cells in mice and humans J. Exp. Med. 180, 1097-1106
55. Brennan, P. J., Tatituri, R. V. V., Brigl, M., Kim, E. Y., Tuli, A., Sanderson, J. P., Gadola, S. D., Hsu, F.-F., Besra, G. S., and Brenner, M. B. (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals Nat. Immunol. 12, 1202-1211
56. Jervis, P. J., Cox, L. R., and Besra, G. S. (2011) Synthesis of a versatile building block for the preparation of 6-N -derivatized α-galactosyl ceramides: Rapid access to biologically active glycolipids J. Org. Chem. 76, 320-323